Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSBR | VRCA | PYXS | ||
| Company | Champions Oncolog | Verrica Pharmaceuticals Inc | Pyxis Oncology Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.97 | 5.61 | 1.3400 | ||
| High | 6.20 | 5.97 | 1.3850 | ||
| Low | 5.97 | 5.61 | 1.3000 | ||
| Latest | 6.08 | 5.69 | 1.3000 | ||
| Change | +0.13 | +0.13 | -0.0500 | ||
| % Change | +2.18% | +2.34% | -3.70% | ||
| Volume | 2,600 | 144,800 | 195,300 | ||
| 20-Day Average Volume | 5,785 | 150,705 | 632,750 | ||
| Previous Close | 5.95 | 5.56 | 1.3500 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.82 | 6.98 | 1.5265 | ||
| 20-Day Raw Stochastic | 9.94% | 9.89% | 2.78% | ||
| 20-Day Relative Strength | 40.81 | 37.01 | 36.00 | ||
| Weighted Alpha | -34.00 | -69.90 | +26.93 | ||
| Today's Opinion | 40% Sell | 8% Sell | 88% Sell | ||
| Previous Opinion | 40% Sell | 8% Sell | 72% Sell | ||
| Last Month's Opinion | 32% Buy | 72% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.18% since 02/06/26 | -17.66% since 02/06/26 | -13.91% since 02/06/26 | ||
| Low | 5.90 on 02/12/26 | 5.41 on 02/12/26 | 1.2800 on 02/11/26 | ||
| High | 6.85 on 02/09/26 | 7.15 on 02/09/26 | 1.5500 on 02/09/26 | ||
| 1-Month | |||||
| %Chg | -13.82% since 01/13/26 | -29.05% since 01/13/26 | -30.85% since 01/13/26 | ||
| Low | 5.90 on 02/12/26 | 5.41 on 02/12/26 | 1.2800 on 02/11/26 | ||
| High | 7.71 on 01/28/26 | 8.24 on 01/21/26 | 2.0300 on 01/14/26 | ||
| 3-Month | |||||
| %Chg | -11.88% since 11/13/25 | +47.03% since 11/13/25 | -70.98% since 11/13/25 | ||
| Low | 5.90 on 02/12/26 | 3.64 on 11/18/25 | 1.0300 on 12/26/25 | ||
| High | 8.31 on 12/15/25 | 9.82 on 11/28/25 | 5.5500 on 11/26/25 | ||
| 6-Month | |||||
| %Chg | -11.11% since 08/13/25 | -13.66% since 08/13/25 | +21.50% since 08/13/25 | ||
| Low | 5.90 on 02/12/26 | 3.28 on 11/04/25 | 1.0300 on 12/26/25 | ||
| High | 8.74 on 09/15/25 | 9.82 on 11/28/25 | 5.5500 on 11/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 84,427 | 90,983 | 80,943 | ||
| Shares Outstanding, K | 13,886 | 15,990 | 62,264 | ||
| Annual Sales | 56,940,000 | 7,570,000 | 16,150,000 | ||
| Annual Net Income | 4,700,000 | -76,580,000 | -77,330,000 | ||
| Last Quarter Sales | 15,040,000 | 14,340,000 | 2,820,000 | ||
| Last Quarter Net Income | 270,000 | -270,000 | -18,350,000 | ||
| 60-Month Beta | 0.36 | 1.46 | 1.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.02 on 12/15/25 | 0.13 on 11/14/25 | -0.35 on 11/03/25 | ||
| Latest Earnings Date | 03/10/26 | 03/10/26 | 03/17/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 35.00 | 0.00 | 0.00 | ||